A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate

Vaccine
Walter WodalThomas R Kreil

Abstract

Influenza viruses of subtype A/H9N2 are enzootic in poultry across Asia and the Middle East and are considered to have pandemic potential. The development of new vaccine manufacturing technologies is a cornerstone of influenza pandemic preparedness. A non-adjuvanted whole-virus H9N2 vaccine was developed using Vero cell culture manufacturing technology. The induction of hemagglutination inhibition (HI) and virus-neutralizing antibodies was assessed in CD1 mice and guinea pigs. A highly sensitive enzyme-linked lectin assay was used to investigate the induction of antibodies capable of inhibiting the enzymatic activity of the H9N2 neuraminidase. Protective efficacy against virus replication in the lung after challenge with the homologous virus was evaluated in BALB/c mice by a TCID(50) assay, and prevention of virus replication in the lung and associated pathology were evaluated by histology and immunohistochemistry. To investigate the ability of the vaccine to prevent severe disease, BALB/c mice were challenged with a highly virulent mouse-adapted H9N2 isolate which was generated by multiple lung-to-lung passage of wild-type virus. The vaccine elicited high titers of functional H9N2-specific HA antibodies in both mice and guinea...Continue Reading

References

May 13, 1999·Antiviral Research·M Kundi
Sep 18, 1999·Lancet·M PeirisK F Shortridge
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·Y P LinA Hay
Nov 30, 2002·Medical Microbiology and Immunology·N HehmeR Sänger
Nov 8, 2005·Journal of Clinical Microbiology·K M ButtYi Guan
Oct 10, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert L AtmarRobert B Couch
Jun 14, 2008·The New England Journal of Medicine·Peter F Wright
Jun 14, 2008·The New England Journal of Medicine·Hartmut J EhrlichUNKNOWN Baxter H5N1 Pandemic Influenza Vaccine Clinical Study Team
Oct 28, 2008·Biological Chemistry·M Keith HowardP Noel Barrett
Feb 13, 2009·The Journal of Infectious Diseases·Ruth A KarronKanta Subbarao
Apr 22, 2009·Proceedings of the National Academy of Sciences of the United States of America·Erin M SorrellDaniel R Perez
Apr 29, 2009·Expert Review of Vaccines·P Noel BarrettM Keith Howard
Aug 29, 2009·The Journal of Infectious Diseases·Hartmut J EhrlichP Noel Barrett
Jul 2, 2010·Journal of Virology·Natalia A IlyushinaRichard J Webby
Mar 4, 2011·Proceedings of the National Academy of Sciences of the United States of America·Yipeng SunJinhua Liu
Jul 7, 2011·Proceedings of the National Academy of Sciences of the United States of America·J Brian KimbleDaniel Roberto Perez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.